OMB
.report
Search
Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents (NCI)
Conference, Meeting, Workshop, and Poster Session Registration Generic Clearance (OD)
OMB: 0925-0740
IC ID: 246765
OMB.report
HHS/NIH
OMB 0925-0740
ICR 202201-0925-002
IC 246765
( )
⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0925-0740 can be found here:
2022-10-19 - No material or nonsubstantive change to a currently approved collection
2022-08-04 - Reinstatement with change of a previously approved collection
Documents and Forms
Document Name
Document Type
Form 1
Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents (NCI)
Form
1 TACPAD
TACPAD.pdf
Form
1 TACPAD
TACPAD.pdf
Form
Sub-Study - TACPAD Workshop 2021 (2).docx
Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents (NCI)
IC Document
Sub-Study - TACPAD Workshop 2021 (2).docx
Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents (NCI)
IC Document
Information Collection (IC) Details
View Information Collection (IC)
IC Title:
Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents (NCI)
Agency IC Tracking Number:
IC Status:
Unchanged
Obligation to Respond:
Voluntary
CFR Citation:
Information Collection Instruments:
Document Type
Form No.
Form Name
Instrument File
URL
Available Electronically?
Can Be Submitted Electronically?
Electronic Capability
Form
1
TACPAD
TACPAD.pdf
Yes
Yes
Fillable Fileable
Federal Enterprise Architecture Business Reference Module
Line of Business:
Health
Subfunction:
Health Care Services
Privacy Act System of Records
Title:
FR Citation:
Number of Respondents:
150
Number of Respondents for Small Entity:
0
Affected Public:
Individuals or Households
Percentage of Respondents Reporting Electronically:
100 %
Requested
Program Change Due to New Statute
Program Change Due to Agency Discretion
Change Due to Adjustment in Agency Estimate
Change Due to Potential Violation of the PRA
Previously Approved
Annual Number of Responses for this IC
150
0
0
0
0
150
Annual IC Time Burden (Hours)
25
0
0
0
0
25
Annual IC Cost Burden (Dollars)
0
0
0
0
0
0
Documents for IC
Title
Document
Date Uploaded
Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents (NCI)
Sub-Study - TACPAD Workshop 2021 (2).docx
04/12/2021
Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.